Bioceres Crop Solutions receives a Buy rating and $15.00 target price from Roth MKM analysts for Q3 2025.

Bioceres Crop Solutions (NASDAQ:BIOX) receives a Buy rating and $15.00 target price from Roth Mkm analysts, who expect the company to earn $0.09 per share for Q3 2025. The stock has a market cap of $695.79m, a P/E ratio of 1,108.00, and a beta of 0.50. Bioceres Crop Solutions reported $0.14 EPS for the last quarter, missing the consensus estimate of $0.16 by $0.02.

July 05, 2024
3 Articles

Further Reading